These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 19319001)

  • 1. Hormone replacement therapy and cardiovascular health in the United States.
    Shetty KD; Vogt WB; Bhattacharya J
    Med Care; 2009 May; 47(5):600-6. PubMed ID: 19319001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmenopausal hormone use in women with acute coronary syndromes.
    Parsons E; Newby LK; Bhapkar MV; Alexander KP; White HD; Shah SH; Bushnell CD; Califf RM;
    J Womens Health (Larchmt); 2004 Oct; 13(8):863-71. PubMed ID: 15671702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program.
    Hillman JJ; Zuckerman IH; Lee E
    J Womens Health (Larchmt); 2004 Nov; 13(9):986-92. PubMed ID: 15665655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk in women with non-specific chest pain (from the Women's Health Initiative Hormone Trials).
    Robinson JG; Wallace R; Limacher M; Ren H; Cochrane B; Wassertheil-Smoller S; Ockene JK; Blanchette PL; Ko MG
    Am J Cardiol; 2008 Sep; 102(6):693-9. PubMed ID: 18773990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence with oral and transdermal hormone replacement therapy and hospitalisation for cardiovascular outcomes.
    Corrao G; Zambon A; Nicotra F; Fornari C; La Vecchia C; Mezzanzanica M; Nappi RE; Merlino L; Cesana G
    Maturitas; 2007 Jul; 57(3):315-24. PubMed ID: 17485182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.
    Prentice RL; Langer RD; Stefanick ML; Howard BV; Pettinger M; Anderson GL; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
    Am J Epidemiol; 2006 Apr; 163(7):589-99. PubMed ID: 16484450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women.
    Alexandersen P; Tankó LB; Bagger YZ; Qin G; Christiansen C
    Climacteric; 2006 Apr; 9(2):108-18. PubMed ID: 16698657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial.
    Prentice RL; Langer R; Stefanick ML; Howard BV; Pettinger M; Anderson G; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
    Am J Epidemiol; 2005 Sep; 162(5):404-14. PubMed ID: 16033876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiovascular risk and hormone replacement therapy in menopause].
    Plu-Bureau G
    Therapie; 1999; 54(3):375-80. PubMed ID: 10500454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons learned from the WHI: HRT requires a cautious and individualized approach.
    Aubuchon M; Santoro N
    Geriatrics; 2004 Nov; 59(11):22-6. PubMed ID: 15615157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication.
    Guay MP; Dragomir A; Pilon D; Moride Y; Perreault S
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):17-27. PubMed ID: 16794994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy among postmenopausal women presenting with acute myocardial infarction: insights from the GUSTO-III trial.
    Tackett AH; Bailey AL; Foody JM; Miller JM; Apperson-Hansen C; Ohman EM; Hochman JS; Karnash SL; Califf RM; Topol EJ; Moliterno DJ
    Am Heart J; 2010 Oct; 160(4):678-84. PubMed ID: 20934562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy and secondary cardiovascular prevention: a meta-analysis of randomized trials.
    Cho L; Mukherjee D
    Cardiology; 2005; 104(3):143-7. PubMed ID: 16118493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy in postmenopausal women.
    Staren ED; Omer S
    Am J Surg; 2004 Aug; 188(2):136-49. PubMed ID: 15249239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current opinions and understandings of menopausal women about hormone replacement therapy (HRT)-the University of Florida experience.
    Levens E; Williams RS
    Am J Obstet Gynecol; 2004 Aug; 191(2):641-6; discussion 646-7. PubMed ID: 15343254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmenopausal hormone replacement therapy and the prevention of cardiovascular disease: a review.
    Abramson BL
    J Cardiovasc Risk; 2002 Dec; 9(6):309-14. PubMed ID: 12478199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of stroke in hypertensive women using hormone therapy: analyses based on the Danish Nurse Study.
    Løkkegaard E; Jovanovic Z; Heitmann BL; Keiding N; Ottesen B; Hundrup YA; Obel EB; Pedersen AT
    Arch Neurol; 2003 Oct; 60(10):1379-84. PubMed ID: 14568807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adverse cardiovascular effects of postmenopausal hormone replacement therapy].
    Middeldorp S; Büller HR; Vandenbroucke JP; Helmerhorst FM; Rosendaal FR
    Ned Tijdschr Geneeskd; 2002 Nov; 146(45):2123-7. PubMed ID: 12474549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.